PLOD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.634600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.239400E-01
Normal-vs-Stage2
9.064200E-01
Normal-vs-Stage3
8.130800E-01
Normal-vs-Stage4
5.924000E-01
Stage1-vs-Stage2
1.302500E-03
Stage1-vs-Stage3
2.249800E-01
Stage1-vs-Stage4
2.422400E-01
Stage2-vs-Stage3
6.881400E-01
Stage2-vs-Stage4
3.801200E-01
Stage3-vs-Stage4
4.177200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.783600E-01
Normal-vs-AfricanAmerican
7.374000E-01
Normal-vs-Asian
7.790400E-01
Caucasian-vs-AfricanAmerican
6.820400E-01
Caucasian-vs-Asian
6.592000E-01
AfricanAmerican-vs-Asian
9.083800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.719600E-01
Normal-vs-Female
8.709200E-01
Male-vs-Female
4.432800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.957600E-01
Normal-vs-Age(41-60Yrs)
6.538800E-01
Normal-vs-Age(61-80Yrs)
9.135800E-01
Normal-vs-Age(81-100Yrs)
6.180800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.354800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.466200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.132000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.481700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.112170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.076800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.959200E-01
Normal-vs-Daily Drinker
5.383400E-01
Normal-vs-Weekly Drinker
7.777400E-01
Normal-vs-Occasional Drinker
6.005800E-01
Normal-vs-Social Drinker
7.819000E-01
Non Drinker-vs-Daily Drinker
9.202400E-01
Non Drinker-vs-Weekly Drinker
3.497200E-01
Non Drinker-vs-Occasional Drinker
7.037700E-02
Non Drinker-vs-Social Drinker
1.896970E-01
Daily Drinker-vs-Weekly Drinker
5.024600E-01
Daily Drinker-vs-Occasional Drinker
8.082200E-02
Daily Drinker-vs-Social Drinker
2.166000E-01
Weekly Drinker-vs-Occasional Drinker
1.465360E-01
Weekly Drinker-vs-Social Drinker
3.840200E-01
Occasional Drinker-vs-Social Drinker
5.464400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.754600E-01
Normal-vs-Grade 2
4.568000E-01
Normal-vs-Grade 3
5.731800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.958900E-03
Grade 1-vs-Grade 3
1.171930E-02
Grade 1-vs-Grade 4
9.754600E-01
Grade 2-vs-Grade 3
3.248400E-01
Grade 2-vs-Grade 4
4.568000E-01
Grade 3-vs-Grade 4
5.731800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.910200E-01
Normal-vs-NonDiabetic
9.806800E-01
Diabetic-vs-NonDiabetic
9.721200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.349200E-01
Normal-vs-NoPancreatitis
9.808000E-01
Pancreatitis-vs-NoPancreatitis
9.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.248800E-01
Normal-vs-N1
8.878400E-01
N0-vs-N1
4.504400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.060000E-01
Normal-vs-TP53-NonMutant
1.798180E-01
TP53-Mutant-vs-TP53-NonMutant
8.397600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
